A Retrospective Study Evaluating the Efficacy of Fludarabine, Cytarabine, and Granulocyte Colony Stimulating Factor with/without Idarubicin Followed by Second Allogenic Stem Cell Transplant in the Treatment of Relapsed/Refractory AML/MDS Following First Allogenic Stem Cell Transplant
{{output}}
Background: Allogeneic stem cell transplantation (allo-SCT) remains the only curative treatment for most patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). Unfortunately, a significant number of patien... ...
